Medications for blood pressure, blood glucose, lipids, and anti-thrombotic medications: relationship with cardiovascular disease and death in adults from 21 high-, middle-, and low-income countries with an elevated body mass index.
Darryl P LeongSumathy RangarajanAnnika RosengrenAytekin OguzKhalid F AlhabibPaul PoirierRafael DiazAntonio L DansRomaina IqbalAfzalhussein M YusufaliKaren YeatesJephat ChifambaPamela SerónJose Lopez-LopezAhmad BahonarLi WeiHu BoLiu WeidaAlvaro AvezumRajeev GuptaViswanathan MohanHerculina S KrugerP V M LakshmiRita YusufSalim YusufPublished in: European journal of preventive cardiology (2022)
To the extent that CVD risk among those with an elevated BMI is related to hypertension, diabetes, and an elevated thrombotic milieu, targeting these pathways pharmacologically may represent an important complementary means of reducing the CVD burden caused by an elevated BMI.